Received: 18 December 2020
Accepted: 23 March 2021
First Online: 31 March 2021
: The CRYSTAL-AF study (RCT# NCT00924638) was conducted in accordance with Good Clinical Practice and ISO-14155 as guidance and in compliance with the Declaration of Helsinki and the laws and regulations of the participating countries. Centers provided written approval from the Institutional Review Board and/or Medical Ethics Committee to participate in the study. Informed consent was obtained from all subjects, all of whom were over 18 years of age.
: Not required; this manuscript does not include details, images, or videos relating to an individual person.
: KKW has received unconditional research funding from Medtronic to the University of Leeds for a PhD Fellowship program and consultancy or speaker fees from Medtronic, Novartis, AstraZeneca, Pfizer, Napp, Abbott, Cardiac Dimensions, and Microport. GT reports no disclosures. VT has received speaker and consultant fees from Boehringer Ingelheim, Bayer, Pfizer, Bristol-Myers Squibb, and Medtronic. MR has received consultancy fees from Medtronic. SIT, SE, EI, RS, JL, RJ, MH, ME, BdB, PDZ, NF, and SL are employees of, and hold shares of, Medtronic.